{"id":"placebo-tablet-and-placebo-patch","safety":{"commonSideEffects":[{"rate":"variable, typically 10-40% depending on condition and trial design","effect":"Placebo effect (symptom improvement without active ingredient)"}]},"_chembl":null,"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Placebo Tablet and Placebo Patch","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T02:37:07.462279+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T02:37:13.851845+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Placebo Tablet and Placebo Patch","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T02:37:14.160275+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1628401/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T02:37:19.334799+00:00"}},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo tablets and patches are inert formulations used as control comparators in clinical trials to measure the effect of patient expectation and the therapeutic ritual independent of any pharmacological action. They allow researchers to distinguish between the true drug effect and the psychological/physiological response to receiving treatment. Placebos are essential tools in randomized controlled trials to establish efficacy and safety of investigational drugs.","oneSentence":"Placebo formulations contain no active pharmaceutical ingredient and produce therapeutic effects solely through the placebo effect.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:01:27.938Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T02:37:21.084044+00:00","fieldsConflicting":0,"overallConfidence":0.95},"indications":{"approved":[{"name":"Clinical trial control comparator (non-therapeutic use)"}]},"trialDetails":[{"nctId":"NCT00713947","phase":"PHASE4","title":"Effectiveness of the Eradication of Helicobacter Pylori and an Inhibitor of Pump With Proton Versus Control","status":"WITHDRAWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2008-04","conditions":"Positive Helicobacter Pylori Serology, Coronary Thrombosis, Supra-aortic Artery Thrombosis","enrollment":""},{"nctId":"NCT06982313","phase":"","title":"Long-term Follow-up of the TAM-01 Study and Pooled Analysis of Low-dose Tamoxifen Studies in Non-invasive or Microinvasive Breast Neoplasms","status":"COMPLETED","sponsor":"Ente Ospedaliero Ospedali Galliera","startDate":"1996-07-01","conditions":"Breast Cancer Invasive","enrollment":1545},{"nctId":"NCT06065670","phase":"PHASE1, PHASE2","title":"Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a Myelin Repair Therapy","status":"NOT_YET_RECRUITING","sponsor":"University of California, San Francisco","startDate":"2026-09-15","conditions":"Demyelinating Diseases, Demyelination; Corpus Callosum, Multiple Sclerosis Brain Lesion","enrollment":44},{"nctId":"NCT05147220","phase":"PHASE3","title":"Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2021-12-16","conditions":"Relapsing Multiple Sclerosis","enrollment":1001},{"nctId":"NCT02162849","phase":"PHASE4","title":"Reward Sensitivity and Pharmacotherapy for Smoking Cessation","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2015-12-14","conditions":"Tobacco Use Cessation","enrollment":204},{"nctId":"NCT02271919","phase":"PHASE4","title":"Varenicline and Combined NRT for Smoking Cessation","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2015-05-14","conditions":"Cigarette Smoker, Tobacco Use Disorder","enrollment":631},{"nctId":"NCT05156281","phase":"PHASE3","title":"Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2021-12-13","conditions":"Relapsing Multiple Sclerosis","enrollment":1011},{"nctId":"NCT03568318","phase":"PHASE3","title":"A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"AbbVie","startDate":"2018-08-09","conditions":"Atopic Dermatitis","enrollment":1533},{"nctId":"NCT05388656","phase":"PHASE4","title":"Estrogen Variability and Irritability During the Menopause Transition","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2022-06-15","conditions":"Menopause, Irritable Mood","enrollment":40},{"nctId":"NCT07226141","phase":"PHASE1, PHASE2","title":"Valproate for the Treatment of Residual Amblyopia","status":"NOT_YET_RECRUITING","sponsor":"Boston Children's Hospital","startDate":"2026-01-01","conditions":"Amblyopia, Amblyopia Unilateral, Amblyopia, Anisometropic","enrollment":28},{"nctId":"NCT05741060","phase":"PHASE2","title":"Effect of Equol Supplementation on Arterial Stiffness and Cognition in Healthy Volunteers","status":"ACTIVE_NOT_RECRUITING","sponsor":"Akira Sekikawa","startDate":"2023-06-29","conditions":"Arterial Stiffness, White Matter Lesions, Cognitive Decline","enrollment":369},{"nctId":"NCT06990854","phase":"NA","title":"Electroacupuncture for PHN: Efficacy and Biomarker Evaluation in a Multicenter, Randomized, Sham-Controlled Trial Protocol","status":"NOT_YET_RECRUITING","sponsor":"Dexiong Han","startDate":"2025-07-01","conditions":"Postherpetic Neuralgia ( PHN )","enrollment":207},{"nctId":"NCT07040280","phase":"PHASE2","title":"Testing the Effect of Sulforaphane, a Compound Naturally Found in Cruciferous Vegetables, on Preventing Melanoma in Patients With a Prior History of Melanoma","status":"NOT_YET_RECRUITING","sponsor":"Eastern Cooperative Oncology Group","startDate":"2025-10-31","conditions":"Melanoma","enrollment":120},{"nctId":"NCT06798571","phase":"PHASE4","title":"Role of Menopause in Thermoregulation","status":"RECRUITING","sponsor":"Penn State University","startDate":"2025-03-01","conditions":"Menopause, Aging","enrollment":24},{"nctId":"NCT02794428","phase":"PHASE2","title":"Chemoprevention of Gastric Carcinogenesis","status":"COMPLETED","sponsor":"Vanderbilt-Ingram Cancer Center","startDate":"2016-09-19","conditions":"Gastric Cancer, Gastric Intestinal Metaplasia","enrollment":91},{"nctId":"NCT00667628","phase":"PHASE2","title":"Phase 2 Study of TAC-101 Combined With Transcatheter Arterial Chemoembolization (TACE) Versus TACE Alone in Japanese Patients With Advanced Hepatocellular Carcinoma","status":"TERMINATED","sponsor":"Taiho Oncology, Inc.","startDate":"2008-04-24","conditions":"Advanced Hepatocellular Carcinoma","enrollment":54},{"nctId":"NCT06372210","phase":"NA","title":"A Trial to Assess a Wearable Patch's Functioning to Detect Medication Ingestion","status":"COMPLETED","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","startDate":"2023-06-26","conditions":"Mental Disorder, Schizophrenia, Major Depressive Disorder","enrollment":54},{"nctId":"NCT05387707","phase":"PHASE3","title":"Study to Evaluate the Efficacy and Safety of Oral Difelikefalin as Adjunct Therapy to a Topical Corticosteroid for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis","status":"TERMINATED","sponsor":"Cara Therapeutics, Inc.","startDate":"2022-08-16","conditions":"Pruritus, Atopic Dermatitis","enrollment":287},{"nctId":"NCT00775463","phase":"PHASE2","title":"Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine","status":"COMPLETED","sponsor":"United Therapeutics","startDate":"2009-05","conditions":"Systemic Sclerosis, Scleroderma","enrollment":148},{"nctId":"NCT05271344","phase":"NA","title":"Oral Immunonutrition With Synbiotics, Omega 3 and Vitamin D in Patients Undergoing Duodenopancreatectomy for Tumoral Lesion.","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire de Liege","startDate":"2022-04-08","conditions":"Pancreatic Cancer, Complication,Postoperative, Surgery","enrollment":74},{"nctId":"NCT03192995","phase":"PHASE2","title":"Treatment With Lorcaserin for Cocaine Use: The TLC Study","status":"TERMINATED","sponsor":"Glenn-Milo Santos","startDate":"2018-01-01","conditions":"Cocaine Use Disorder","enrollment":22},{"nctId":"NCT03762265","phase":"PHASE3","title":"A Study of PRN1008 in Patients With Pemphigus","status":"TERMINATED","sponsor":"Principia Biopharma, a Sanofi Company","startDate":"2019-01-08","conditions":"Pemphigus","enrollment":131},{"nctId":"NCT05789186","phase":"EARLY_PHASE1","title":"Clinical Study of Cang Ai Volatile Oil (CAVO) on Mild to Moderate Depression in Children and Adolescents","status":"UNKNOWN","sponsor":"Chen Qian","startDate":"2023-05-01","conditions":"Depression","enrollment":108},{"nctId":"NCT05301660","phase":"EARLY_PHASE1","title":"Effect of Nicotine Transdermal Patch on Cognitive Function and Glycolipid Metabolism in Non-smoking Schizophrenia","status":"UNKNOWN","sponsor":"Sir Run Run Shaw Hospital","startDate":"2022-03-22","conditions":"Schizophrenia","enrollment":80},{"nctId":"NCT02122198","phase":"NA","title":"Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2014-09-08","conditions":"Cognitive Impairment, Executive Dysfunction, Endothelial Dysfunction","enrollment":17},{"nctId":"NCT02091882","phase":"PHASE4","title":"Substudy of the Accuracy of Ingestible Event Marker (IEM) Detection by the Medical Information Device #1 (MIND1)","status":"COMPLETED","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","startDate":"2014-03-21","conditions":"Device Latency","enrollment":30},{"nctId":"NCT04982900","phase":"PHASE2","title":"Treatment of EGFR-TKI for Residual Lesions of Multiple Synchronous Ground-glass Opacities","status":"UNKNOWN","sponsor":"Ruijin Hospital","startDate":"2021-10-01","conditions":"Multiple Primary Lung Cancers","enrollment":138},{"nctId":"NCT02859142","phase":"PHASE4","title":"Varenicline Augmentation of Patch Outcomes in Heavy Drinkers' Smoking Cessation","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2018-03-29","conditions":"Smoking Cessation, Alcohol Drinking","enrollment":122},{"nctId":"NCT03208790","phase":"PHASE2","title":"Clinical and Immunohisochemical Evaluation of Chemopreventive Effect of Thymoquinone on Oral Potentially Malignant Lesions.","status":"COMPLETED","sponsor":"Cairo University","startDate":"2017-09-30","conditions":"Premalignant Lesion","enrollment":48},{"nctId":"NCT01320033","phase":"PHASE2","title":"Placebo Controlled Efficacy and Safety Study of CD2475/101 40 mg Tablets vs. Placebo and Doxycycline 100 mg Capsules Once Daily in the Treatment of Inflammatory Lesions of Acne Vulgaris","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2011-03-29","conditions":"Acne Vulgaris","enrollment":662},{"nctId":"NCT04035603","phase":"PHASE2","title":"Multimodal Cue Exposure Therapy for Smoking Cessation","status":"WITHDRAWN","sponsor":"Boston University Charles River Campus","startDate":"2020-10-01","conditions":"Smoking Cessation","enrollment":""},{"nctId":"NCT04329923","phase":"PHASE2","title":"The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine)","status":"TERMINATED","sponsor":"Ravi Amaravadi, MD","startDate":"2020-04-09","conditions":"COVID-19","enrollment":173},{"nctId":"NCT00089843","phase":"PHASE2, PHASE3","title":"Bone Loss in Women With Anorexia Nervosa","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2003-06","conditions":"Anorexia Nervosa","enrollment":77},{"nctId":"NCT04278599","phase":"PHASE4","title":"Effect of Oral Zinc Supplementation as an Adjuvant to Topical Corticosteroid in Oral Lichen Planus Patients","status":"UNKNOWN","sponsor":"Postgraduate Institute of Dental Sciences Rohtak","startDate":"2020-01-15","conditions":"Oral Lichen Planus","enrollment":42},{"nctId":"NCT01212770","phase":"PHASE3","title":"PALACE 3: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis","status":"COMPLETED","sponsor":"Amgen","startDate":"2010-09-30","conditions":"Psoriatic Arthritis","enrollment":505},{"nctId":"NCT02256540","phase":"NA","title":"The Effects of Resveratrol and Acute Exercise on Endothelial Function in Postmenopausal Women","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2014-08","conditions":"Endothelial Dysfunction","enrollment":25},{"nctId":"NCT03967327","phase":"PHASE3","title":"A Study to Evaluate Buprenorphine Transdermal Patch in Chinese Subjects With Moderate to Severe Chronic Cancer Pain","status":"UNKNOWN","sponsor":"Mundipharma (China) Pharmaceutical Co. Ltd","startDate":"2019-04-22","conditions":"Cancer Pain","enrollment":194},{"nctId":"NCT01126645","phase":"PHASE2","title":"Sorafenib and Micro-therapy Guided by Primovist Enhanced MRI in Patients With Inoperable Liver Cancer","status":"COMPLETED","sponsor":"University of Magdeburg","startDate":"2010-12","conditions":"Hepatocellular Carcinoma","enrollment":529},{"nctId":"NCT01999114","phase":"PHASE1","title":"The Effect of Buprenorphine Delivered by Buprenorphine Transdermal System (BTDS) at Doses up to 80 Micrograms/Hour (mcg/hr) and Naltrexone on Electrocardiogram (ECG) Intervals in Healthy Volunteers","status":"COMPLETED","sponsor":"Purdue Pharma LP","startDate":"2012-03","conditions":"ECG Effects","enrollment":328},{"nctId":"NCT00066157","phase":"PHASE2, PHASE3","title":"Alzheimer's Disease: Therapeutic Potential of Estrogen","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2001-09","conditions":"Alzheimer Disease","enrollment":42},{"nctId":"NCT02404532","phase":"PHASE4","title":"Substudy 'B' of the Accuracy of Ingestible Event Marker (IEM) Detection by the Medical Information Device #1 (MIND1)","status":"COMPLETED","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","startDate":"2015-02","conditions":"Device Latency","enrollment":30},{"nctId":"NCT01139996","phase":"PHASE4","title":"Use of Transdermal Clonidine in Trauma Patients","status":"TERMINATED","sponsor":"Memorial Health University Medical Center","startDate":"2010-05","conditions":"Delirium","enrollment":22},{"nctId":"NCT00000437","phase":"PHASE4","title":"Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone)","status":"COMPLETED","sponsor":"The Scripps Research Institute","startDate":"1997-09-26","conditions":"Alcoholism, Smoking","enrollment":60},{"nctId":"NCT00852540","phase":"PHASE3","title":"Retapamulin Versus Linezolid in the Treatment of SITL and Impetigo Due to MRSA","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2009-04","conditions":"Skin Infections, Bacterial","enrollment":410},{"nctId":"NCT02524561","phase":"NA","title":"KEEPS Mammographic Density And Breast Health Ancillary Study","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2005-09","conditions":"Mammographic Density, Abnormal Mammogram","enrollment":517},{"nctId":"NCT02616068","phase":"PHASE3","title":"Comparative Study of Loxoprofen Sodium Transdermal Patch and Loxonin® Tablets for the Treatment of Acute Trauma","status":"COMPLETED","sponsor":"Daiichi Sankyo Brasil Farmacêutica LTDA","startDate":"2015-10","conditions":"Trauma, Pain","enrollment":242},{"nctId":"NCT01074554","phase":"PHASE1, PHASE2","title":"Trial of Antimycobacterial Therapy in Sarcoidosis","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2010-02","conditions":"Sarcoidosis","enrollment":30},{"nctId":"NCT00030147","phase":"PHASE4","title":"Raloxifene and Rimostil for Perimenopause-Related Depression","status":"COMPLETED","sponsor":"National Institute of Mental Health (NIMH)","startDate":"2002-02","conditions":"Perimenopausal Depression, Depression","enrollment":65},{"nctId":"NCT01082874","phase":"PHASE3","title":"PeriOperative ISchemic Evaluation-2 Trial","status":"COMPLETED","sponsor":"Hamilton Health Sciences Corporation","startDate":"2010-07","conditions":"Cardiovascular Disease","enrollment":10010},{"nctId":"NCT01772199","phase":"PHASE2","title":"Study to Assess Whether GSK239512 Can Remyelinate Lesions in Subjects With Relapsing Remitting Multiple Sclerosis","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2013-02","conditions":"Multiple Sclerosis, Relapsing-Remitting","enrollment":131},{"nctId":"NCT01456936","phase":"PHASE4","title":"Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders","status":"COMPLETED","sponsor":"Pfizer","startDate":"2011-11","conditions":"Smoking Cessation","enrollment":8144},{"nctId":"NCT01314001","phase":"PHASE3","title":"Pharmacogenetics of Nicotine Addiction Treatment","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2010-12","conditions":"Nicotine Addiction","enrollment":1246},{"nctId":"NCT00920985","phase":"PHASE3","title":"US Cycle Control and Blood Pressure Study","status":"COMPLETED","sponsor":"Bayer","startDate":"2009-06","conditions":"Contraception","enrollment":346},{"nctId":"NCT02517957","phase":"PHASE2","title":"Xia Shi Surgical Treatment for Eczema Multi-center Clinical Research","status":"UNKNOWN","sponsor":"Shanghai Yueyang Integrated Medicine Hospital","startDate":"2015-08","conditions":"Eczema","enrollment":342},{"nctId":"NCT00151970","phase":"PHASE2","title":"Efficacy, Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD","status":"COMPLETED","sponsor":"Noven Therapeutics","startDate":"2005-06","conditions":"Attention Deficit Disorder With Hyperactivity","enrollment":128},{"nctId":"NCT00444574","phase":"PHASE3","title":"Safety and Efficacy of MTS Versus Concerta in Pediatric Patients (Aged 6-12 Years) With ADHD","status":"COMPLETED","sponsor":"Noven Therapeutics","startDate":"2004-09","conditions":"Attention Deficit Hyperactivity Disorder","enrollment":282},{"nctId":"NCT01387672","phase":"PHASE3","title":"Nitrates and Bone Turnover; Nitrates and Bone Turnover Bisphosphonate Sub-Study","status":"COMPLETED","sponsor":"University of Toronto","startDate":"2011-09","conditions":"Osteoporosis","enrollment":265},{"nctId":"NCT01628926","phase":"PHASE3","title":"A Placebo- and Ropinirole-Controlled Study for SPM 962 in Advanced Parkinson's Disease Patients","status":"COMPLETED","sponsor":"Otsuka Pharmaceutical Co., Ltd.","startDate":"2009-06","conditions":"Parkinson's Disease","enrollment":420},{"nctId":"NCT00308763","phase":"NA","title":"Nicotine Patch and Bupropion to Reduce Smoking Rates in Younger, Low-Income, and Minority Individuals","status":"COMPLETED","sponsor":"University of Tennessee","startDate":"2004-01","conditions":"Tobacco Use Disorder","enrollment":594},{"nctId":"NCT01259115","phase":"PHASE1","title":"Buprenorphine Accumulation and Description of Its Metabolites During Co-Medication of Buprenorphine Transdermal System (BTDS) and Ketoconazole","status":"COMPLETED","sponsor":"Purdue Pharma LP","startDate":"2002-10","conditions":"Healthy","enrollment":20},{"nctId":"NCT00659737","phase":"NA","title":"Comparison of Oral Aprepitant and Transdermal Scopolamine for Preventing Postoperative Nausea and Vomiting","status":"COMPLETED","sponsor":"Drexel University College of Medicine","startDate":"2008-04","conditions":"Nausea, Vomiting","enrollment":115},{"nctId":"NCT01097902","phase":"PHASE1","title":"Study of Experimental Models of Pain and Inflammation.","status":"COMPLETED","sponsor":"Martin Angst","startDate":"2010-02","conditions":"Pain, Inflammation","enrollment":15},{"nctId":"NCT01148537","phase":"PHASE1","title":"The Effect of Buprenorphine Delivered by Buprenorphine Transdermal System (BTDS) on QT Intervals in Healthy Volunteers","status":"COMPLETED","sponsor":"Purdue Pharma LP","startDate":"2004-07","conditions":"Healthy Volunteers","enrollment":132},{"nctId":"NCT00315445","phase":"PHASE3","title":"The Safety and Efficacy of the Buprenorphine Transdermal System (BTDS) in Subjects With Chronic Back Pain.","status":"COMPLETED","sponsor":"Purdue Pharma LP","startDate":"1997-12","conditions":"Back Pain","enrollment":134},{"nctId":"NCT00552799","phase":"PHASE4","title":"RCT to Investigate if Prophylactic Antibiotics Prevent Further Episodes of Cellulitis (Erysipelas) of the Leg","status":"COMPLETED","sponsor":"University of Nottingham","startDate":"2006-07","conditions":"Cellulitis/Erysipelas of the Leg","enrollment":274},{"nctId":"NCT01450839","phase":"PHASE1","title":"E2022 Patch Formulation Multiple Dose Study","status":"COMPLETED","sponsor":"Eisai Co., Ltd.","startDate":"2011-09","conditions":"Healthy","enrollment":16},{"nctId":"NCT00306787","phase":"PHASE3","title":"Efficacy and Safety of Famciclovir 1-day Treatment Compared to 3-day Treatment With Valacyclovir in Adults With Recurrent Genital Herpes","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2006-03","conditions":"Genital Herpes","enrollment":1179},{"nctId":"NCT00860925","phase":"PHASE4","title":"PeriOperative ISchemic Evaluation-2 Pilot","status":"COMPLETED","sponsor":"McMaster University","startDate":"2009-05","conditions":"Cardiovascular Disease","enrollment":90},{"nctId":"NCT00313105","phase":"PHASE2, PHASE3","title":"Smoking Cessation With Smokeless Tobacco, Nicotine Tablets and Nicotine Patches","status":"UNKNOWN","sponsor":"University Hospital, Gentofte, Copenhagen","startDate":"2006-04","conditions":"Tobacco Dependence","enrollment":600},{"nctId":"NCT00622752","phase":"PHASE2","title":"Effects of EVT 302 With or Without NRT on Craving and Withdrawal in Healthy Male Smokers Deprived of Cigarettes","status":"COMPLETED","sponsor":"Evotec Neurosciences GmbH","startDate":"2008-02","conditions":"Smoking Cessation","enrollment":90}],"_emaApprovals":[],"_faersSignals":[],"crossReferences":{"chemblId":"CHEMBL1628401"},"_approvalHistory":[],"publicationCount":13,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Placebo Tablet and Placebo Patch","genericName":"Placebo Tablet and Placebo Patch","companyName":"The Scripps Research Institute","companyId":"the-scripps-research-institute","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Placebo Tablet and Placebo Patch are inert substances used as controls in clinical trials, with the Placebo Patch being a transdermal delivery system. They are small molecule substances, used as comparators in studies for conditions such as Relapsing Multiple Sclerosis, Smoking Cessation, and Multiple Primary Lung Cancers.","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":1,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T02:37:21.084044+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}